These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25323660)

  • 1. Persistent centripetal fat distribution and metabolic abnormalities in patients in long-term remission of Cushing's syndrome.
    Wagenmakers M; Roerink S; Gil L; Plantinga T; Smit J; Netea-Maier R; Hermus A
    Clin Endocrinol (Oxf); 2015 Feb; 82(2):180-7. PubMed ID: 25323660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent body fat mass and inflammatory marker increases after long-term cure of Cushing's syndrome.
    Barahona MJ; Sucunza N; Resmini E; Fernández-Real JM; Ricart W; Moreno-Navarrete JM; Puig T; Farrerons J; Webb SM
    J Clin Endocrinol Metab; 2009 Sep; 94(9):3365-71. PubMed ID: 19509101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipokines and cardiovascular risk in Cushing's syndrome.
    Valassi E; Biller BM; Klibanski A; Misra M
    Neuroendocrinology; 2012; 95(3):187-206. PubMed ID: 22057123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the metabolic phenotypes of Cushing's syndrome and growth hormone deficiency: a study of body composition and energy metabolism.
    Burt MG; Gibney J; Ho KK
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):436-43. PubMed ID: 16584517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body composition determinants of metabolic phenotypes of obesity in nonobese and obese postmenopausal women.
    Peppa M; Koliaki C; Papaefstathiou A; Garoflos E; Katsilambros N; Raptis SA; Hadjidakis DI; Dimitriadis GD
    Obesity (Silver Spring); 2013 Sep; 21(9):1807-14. PubMed ID: 23696298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body composition and bone mineral density in women with Cushing's syndrome in remission and the association with common genetic variants influencing glucocorticoid sensitivity.
    Ragnarsson O; Glad CA; Bergthorsdottir R; Almqvist EG; Ekerstad E; Widell H; Wängberg B; Johannsson G
    Eur J Endocrinol; 2015 Jan; 172(1):1-10. PubMed ID: 25422351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased osteoprotegerin levels in Cushing's syndrome are associated with an adverse cardiovascular risk profile.
    Dovio A; Allasino B; Palmas E; Ventura M; Pia A; Saba L; Aroasio E; Terzolo M; Angeli A
    J Clin Endocrinol Metab; 2007 May; 92(5):1803-8. PubMed ID: 17327380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body composition after endogenous (Cushing's syndrome) and exogenous (rheumatoid arthritis) exposure to glucocorticoids.
    Resmini E; Farkas C; Murillo B; Barahona MJ; Santos A; Martínez-Momblán MA; Roig O; Ybarra J; Geli C; Webb SM
    Horm Metab Res; 2010 Jul; 42(8):613-8. PubMed ID: 20514604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipokine levels in Cushing's syndrome; elevated resistin levels in female patients with Cushing's syndrome.
    Krsek M; Silha JV; Jezková J; Hána V; Marek J; Weiss V; Stepán JJ; Murphy LJ
    Clin Endocrinol (Oxf); 2004 Mar; 60(3):350-7. PubMed ID: 15009001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic and cardiovascular outcomes in patients with Cushing's syndrome of different aetiologies during active disease and 1 year after remission.
    Giordano R; Picu A; Marinazzo E; D'Angelo V; Berardelli R; Karamouzis I; Forno D; Zinnà D; Maccario M; Ghigo E; Arvat E
    Clin Endocrinol (Oxf); 2011 Sep; 75(3):354-60. PubMed ID: 21521323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
    Robaczyk MG
    Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body composition and metabolic features in women with adrenal incidentaloma or Cushing's syndrome.
    Garrapa GG; Pantanetti P; Arnaldi G; Mantero F; Faloia E
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5301-6. PubMed ID: 11701696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic comorbidities in Cushing's syndrome.
    Ferraù F; Korbonits M
    Eur J Endocrinol; 2015 Oct; 173(4):M133-57. PubMed ID: 26060052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of adipose tissue derived genes in endogenous Cushing's syndrome versus diet-induced obesity.
    Denes J; Zsippai A; Kovacs L; Gorombey Z; Kovacs GL; Goth M; Igaz P; Hubina E
    Endokrynol Pol; 2019; 70(2):131-134. PubMed ID: 30480750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between breast adipose tissue, body fat distribution and cardiometabolic risk in women: cross-sectional data and weight-loss intervention.
    Schautz B; Later W; Heller M; Müller MJ; Bosy-Westphal A
    Eur J Clin Nutr; 2011 Jul; 65(7):784-90. PubMed ID: 21427743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gluteofemoral body fat as a determinant of metabolic health.
    Manolopoulos KN; Karpe F; Frayn KN
    Int J Obes (Lond); 2010 Jun; 34(6):949-59. PubMed ID: 20065965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Plasma leptin levels in relation to body composition and body fat distribution in patients with Cushing's syndrome].
    Robaczyk M; Krzyzanowiska-Swiniarska B; Andrysiak-Mamos E; Kulig G; Pilarska K
    Pol Arch Med Wewn; 2003 Nov; 110(5):1299-308. PubMed ID: 16737000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired quality of life in patients in long-term remission of Cushing's syndrome of both adrenal and pituitary origin: a remaining effect of long-standing hypercortisolism?
    Wagenmakers MA; Netea-Maier RT; Prins JB; Dekkers T; den Heijer M; Hermus AR
    Eur J Endocrinol; 2012 Nov; 167(5):687-95. PubMed ID: 22936421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
    Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zinc alpha-2 glycoprotein is overproduced in Cushing's syndrome.
    Escoté X; Aranda GB; Mora M; Casals G; Enseñat J; Vidal O; Esteban Y; Halperin I; Hanzu FA
    Endocrinol Diabetes Nutr; 2017 Jan; 64(1):26-33. PubMed ID: 28440767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.